Bacterial Cellulose-monolaurin Hydrogel for Acute Radiation Dermatitis
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Acute Radiation Dermatitis
In brief
Acute radiation dermatitis (ARD) is almost universally experienced by patients with cancer during or after radiation therapy. This condition potentially leads to detrimental clinical outcomes as it adversely affects adherence to prescribed subsequent management and further worsens quality of life. Nevertheless, there remains no consensus on the appropriate intervention for ARD. This pilot two parallel-group randomized trial aims to clinically assess the potential of bacterial cellulose-monolaurin hydrogel, compared to placebo cream, to prevent high-grade ARD among Filipinos with breast cancer up to four weeks after last radiotherapy session.
Key facts
- Study ID
- NCT05079763
- Run by
- University of the Philippines
- People needed
- 54
- Starts
- 2021-09-01
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2026-01-12
Who can join
Age: 18 and older, up to 80. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female sex at birth
- Age at least 18 years at the time of invitation
- Eastern Cooperative Oncology Group (ECOG) Performance Status score of either 0 or 1
- With histopathologic diagnosis of breast carcinoma
- Already completed prescribed mastectomy and chemotherapy (adjuvant or neoadjuvant) interventions
- Scheduled to receive hypo fractionated postmastectomy-postchemotherapy radiation therapy
You may not qualify if…
- Pregnant or lactating
- With concurrent or previous history of any malignancy
- With history of mediastinal or thoracic irradiation
- With current bilateral synchronous breast carcinoma
- With diagnosis of metastases from any form of breast cancer
- With any skin lesion in the planned radiation field deemed deramtologically and/or radiotherapeutically relevant
- With concomitant disease states deemed clinically significant (connective tissue diseases, infections, uncontrolled chronic disorders, renal failure, hepatic dysfunction, etc.)
- With known history of hypersensitivities and/or reactions against any component of either experimental or comparator interventions
- Inability to personally provide informed consent or to personally comply with skin care instructions
Where it is running
- Philippine General Hospital — Manila, Philippines (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.